Stem Cell Therapies Manufacturing Labs & Office TI
MAI completed four (4) phases to build the new Novo Nordisk’s Stem Cell manufacturing lab and office space, a facility used to develop Stem Cell based therapies across multiple chronic disease areas.
Phase A and Phase B included building cGMP Grade B manufacturing labs, including providing a new material lift and a new canopy at the shipping and receiving area. cGMP part includes refinishing the QC Lab, Locker rooms, CNC corridors and two (2) cGMP Labs.
Phase C and Preliminary Office Works included the office area TI, including new break area open office collaborative spaces, refinish the office rooms and widen the stair opening concrete deck for future equipment delivery to second floor.